疼痛改革
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About 疼痛改革
PainReform Ltd. 是一家臨床階段的專業製藥公司，在以色列從事可提供長期術後鎮痛的療法開發。它致力於開發 PRF-110，這是一種粘稠的透明油基溶液，可直接滴入手術傷口以提供局部和延長的術後鎮痛。該公司目前正在進行 PRF-110 的兩項 3 期臨床試驗，用於治療接受拇囊炎切除手術和疝修補術的患者。 PainReform Ltd. 成立於 2007 年，總部位於以色列特拉維夫。
如何購買 疼痛改革 (PRFX)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 PRFX
透過 RockFlow App 或網頁端搜尋 PRFX，輸入您想要投資的金額，然後點擊確認即可完成交易。
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.